Adicet Bio (ACET) Other Working Capital Changes (2017 - 2026)

Adicet Bio has reported Other Working Capital Changes for 10 years, with the latest figure at -$1.0 million in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 17.72% year-over-year to -$1.0 million in Q2 2026; TTM through Jun 2026 was -$3.4 million, a 9.01% increase from a year earlier, with the FY2025 full-year figure at -$3.4 million, up 6.56% from the prior year.
• Other Working Capital Changes was -$1.0 million for Q2 2026 at Adicet Bio, down from -$817000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $2.5 million in Q2 2020, with the low at -$5.4 million in Q4 2020.
• Average Other Working Capital Changes over 4 years is -$2.9 million, with a median of -$3.0 million recorded in 2020.
• The largest YoY upside for Other Working Capital Changes was 329.71% in 2023 against a maximum downside of 321.67% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$568000.0 in 2022, then plunged by 199.12% to -$1.7 million in 2023, then jumped by 43.2% to -$965000.0 in 2024, then climbed by 17.51% to -$796000.0 in 2025, then slumped by 31.03% to -$1.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.0 million (Q2 2026), -$817000.0 (Q1 2026), and -$796000.0 (Q4 2025), per Business Quant data.